Listing of Turbo warrants issued by Morgan Stanley & Co.

Bobby Perez Joins Thrive Aviation to Spearhead Charter Sales Private aviation isn't just about getting a ride anymore; it's the balance of luxury and logistic know-how. Enter Bobby Perez, the latest addition to Thrive Aviation's brain trust. With Thrive hanging its hat on being a top-tier name in private jets, snagging a veteran like Perez is the kind of move savvy...

Seems Lululemon just tripped on its yoga mat. When a company like Lululemon Athletica, Inc (NASDAQ:LULU) sees a 17.38% slide in stock, every savvy investor knows there's more beneath the surface. Squarely in the crosshairs of a securities fraud class action, the brand synonymous with upscale athleisure faces harsh scrutiny. And the deadline's ticking—even the suits know...

Mill Creek Sets Up Shop in McKinney You ever watch these neighborhoods sprout up like they’re out of nowhere? Seems like every time you blink, there’s another bunch of homes cropping up. Mill Creek Residential’s latest offering, Modera Ridgeline, joins the ranks with its 325 homes getting ready for squatters who prefer a bit of nature with their suburban sprawl....

Unpacking Azitra's Recent Breakthroughs Azitra, Inc. galloped into the spotlight with their Q3 2026 financials and some hefty business updates. This isn’t just about dollars and cents; they've got some fascinating biotech news wrapped in. Riding High on ATR-COSF Ex Vivo Results All eyes are on Azitra’s ATR-COSF. The lab is lighting up with news — a 50% wrinkle...

Genesis One Enters the Fray with Home-Based Wellness In a health industry where everyone's screaming for transparency and flexibility, Genesis One is finding a sweet spot. They're throwing their hat in the ring with a new telehealth wellness pitch. Now, this isn't your everyday launch—it's a prelude to a January 2027 rollout, with co-founders Brent Messer and Dr. Alex...

Flor de Caña’s Environmental Triumph Seems like when folks think of premium rum, they might wanna start picturing not just smooth sips but a green commitment that runs deep. Flor de Caña has bagged a Stevie Award for their solid 'Net Zero Strategy of the Year.' This ain’t just any award; it's a nod from a respected crowd. A handshake from the business big shots who...

Antengene's Ambitious Move in Autoimmune Diseases In a world where biotech buzzwords often outshine real data, Antengene's latest presentation at the 2026 American College of Rheumatology Annual Meeting packs a punch with its preclinical findings on ATG-207. This bifunctional fusion protein is paving the way for novel treatments targeting pesky T cell–mediated...

When the world loses a healer like Dr. Rizk Abu Shaaira to an airstrike, it feels like we're spiraling further into a pit where humanity becomes collateral damage. Dr. Shaaira, a prominent Palestinian surgeon, found his life brutally cut short amid violence that's becoming as depressingly routine as my morning coffee—a routine nobody asked for. The Unforgiving Reality...

Healthcare Payment Preferences: A Deeper Look The Paytient-Greenwald study is rocking the boat, unveiling how insured folks opt to pay for healthcare cash and steer clear of claims. A Shift Towards Payability in Insurance We’re seeing something unusual with these findings—a staggering 61% of insured folks shelling out cash without ever filing a claim. Imagine paying...

Unexpected Performance Amidst Challenging Circumstances I'll tell you, navigating through operational bottlenecks is no small feat, but Natura seems to be brewing its own survival recipe. They reported a net income of BRL 49 million in the third quarter of 2026, clawing back from a net loss of BRL 119 million in the previous year. That's no magic trick; it's a reflection...

Nipocalimab: A Breakthrough in Treating IgG-Driven Diseases Nipocalimab has emerged as a promising investigational treatment in the realm of IgG-driven alloantibody and autoantibody diseases. Recent results affirm its high-affinity binding characteristics and immunoselective properties. This groundbreaking monoclonal antibody has been shown to significantly reduce IgG...

FTI Consulting Reports Third Quarter Financial Results FTI Consulting, Inc. (NYSE: FCN) recently announced its financial performance for the third quarter, presenting a noteworthy achievement with earnings of $926 million, marking an increase compared to the previous year. This growth reflects the company's resilience and capacity to adapt amidst fluctuating market...

FutureFuel Achieves Excise Tax Registration Approval FutureFuel Corp. (NYSE: FF), a leading player in the manufacturing of custom and performance chemicals and biofuels, has recently celebrated a significant success. The company has received its Excise Tax Registration approval from the Internal Revenue Service (IRS). This vital registration marks the first step towards...

Natural Gas Services Group Announces Strong Q3 2024 Results Natural Gas Services Group, Inc. (NYSE: NGS), a prominent provider in the natural gas compression industry, has released its financial results for the third quarter ending September 30, 2024. The company reported significant growth in rental revenue, cash flow from operating activities, and net income, signifying...

Apple Inc. Enters a New Era with C2 Modem Testing Apple Inc. (NASDAQ: AAPL) is taking significant steps in advancing its connectivity technology by reportedly testing its second-generation C2 modem for the upcoming iPhone models. Latest Developments in Modem Technology Recently, a reliable source on X, previously known as Twitter, revealed that Apple is currently in the...